Aidoc Secures $150M to Scale AI Imaging Tools
Aidoc, a New York‑based AI imaging firm, announced a $150 million Series E round that lifts its cumulative capital to over $500 million. The round was led by Goldman Sachs Alternatives with participation from General Catalyst, SoftBank Investment Advisors and NVIDIA’s venture arm. Proceeds will fund global expansion, the development of its CARE foundation model, and new capabilities such as automated draft‑report creation. The company also recently secured FDA clearance for a combined‑indication triage tool covering 14 acute findings.
DHL Express Joins Forces with Air Ambulances UK
DHL Express UK has entered a national partnership with Air Ambulances UK, the umbrella charity for the country’s 21 air‑ambulance services. The deal will channel raised funds evenly across all member charities, reinforcing the financial base that powers rapid‑response missions....
Health Disparities Persist Across States and May Widen Further with Federal Cuts: Report
A Commonwealth Fund report finds racial and ethnic health disparities persist across all 50 states despite modest gains in coverage after the pandemic. Native, Hispanic and Black populations face worse access and affordability than whites, and outcomes such as mortality...
Brain Function Evaluations to Be Part of Marine Health Records
The U.S. Marine Corps is embedding computerized brain‑function assessments (ANAM) into its health records to track blast‑related injuries. Baseline ANAM testing now covers high‑risk personnel such as weapons instructors, with full integration into annual health exams slated for September 2027....
Genome Editing Can Be Risky. Meet the Epigenome Editors
Scientists are turning to epigenome editors—tools that rewrite gene activity without altering the DNA sequence—to sidestep the safety concerns of traditional genome editing. By coupling dead Cas9 (dCas9) with epigenetic modifiers, researchers can turn genes on or off with high...
Simple Treatment Tweak Drastically Reduces Blood Loss From Severe Cuts
Researchers at McGill University have engineered red blood cells to form rapid, durable clots, stopping severe bleeding in rat liver wounds within five seconds. Treated rats lost only 24 mg of blood versus nearly 2,000 mg in controls, and the clots remained...
UHS Reaffirms 2026 Volume Targets, Despite Seasonal Hits in Q1
Universal Health Services (UHS) said its first‑quarter admissions slipped due to a milder respiratory season and winter storms, with acute‑care volumes down 200 basis points and behavioral‑health volumes down 40‑50 basis points. Despite the dip, the for‑profit hospital chain reaffirmed...
ASRT to Award Life Membership to Three Members
The American Society of Radiologic Technologists (ASRT) will confer Life Member status on three distinguished members—Donna Newman, Marilyn Sackett, and Joseph Whitton—at its Annual Governance and House of Delegates Meeting in Albuquerque on June 26. Life Membership, established in 1938,...
FDA to Pilot Real-Time Clinical Drug Trials Through Cloud and AI
The FDA announced a pilot that will stream clinical‑trial data to the agency in real time using cloud platforms and artificial‑intelligence analytics. Commissioner Marty Makary said the effort could shave up to 40% off the time between Phase 1 trials and...
Daytime Napping and Mortality Association in Older Adults
A JAMA Network Open study of 1,338 older adults used wrist actigraphy to objectively measure daytime napping patterns and found that longer nap duration and higher nap frequency are linked to increased all‑cause mortality. Each additional hour of napping adds...
Prenatal Surgery for Spina Bifida May Get a Boost From Stem Cells
Researchers at UC Davis have performed the first in‑utero repair of spina bifida using a stem‑cell‑infused patch on six fetuses. The procedure appeared safe, with no infections, tumors, or delayed healing reported in the initial cohort. While early safety data...
The Tobacco Endgame
The UK Parliament has passed the 2026 Tobacco and Vapes Act, introducing a generational ban that prohibits selling cigarettes, herbal smoking products and cigarette papers to anyone born on or after 1 January 2009. The law also creates a retail licensing scheme...
Treasury Proposes RM5.45 Billion Budget Cuts for Health, Higher Education
Malaysia's Treasury has proposed cutting RM5.45 billion (≈$1.2 billion) from operating expenditures in the health and higher‑education ministries, part of a broader RM10 billion (≈$2.2 billion) savings drive. The health ministry faces a RM3.06 billion cut while higher education will lose RM2.39 billion, as subsidy demands...
Bristol Myers Reaches a Crossroads as a Make-or-Break Year Takes Shape
Bristol Myers Squibb (BMS) is at a strategic inflection point as 2024 becomes a make‑or‑break year for the drugmaker. CEO Chris Boerner, now 2½ years in charge, must navigate a looming patent cliff on its flagship immunotherapy, integrate the recent Mirati Oncology...
Henlius and Organon Gain EC Approval for Pertuzumab Biosimilar
Henlius and Organon have received the first European marketing authorization for a pertuzumab biosimilar, Poherdy, targeting HER2‑positive breast cancer. The EC approval mirrors the product’s earlier U.S. clearance and covers all indications of Roche’s reference drug, Perjeta, including metastatic, neoadjuvant...
Pfizer Earns Positive Phase 3 in Multiple Myeloma; ICON Overstated Revenue
Pfizer announced that its antibody‑drug conjugate Elrexfio achieved a statistically significant and clinically meaningful improvement in progression‑free survival for patients with double‑class exposed relapsed or refractory multiple myeloma. The Phase 3 trial met its primary endpoint, positioning the drug as a...
Albertsons Expands Free Curbside Prescription Pickup Nationwide
Albertsons Companies announced that its DriveUp & Go service now offers free curbside pickup for eligible pharmacy prescriptions at more than 1,700 stores nationwide. Customers can order online or via the Albertsons app, select a pickup window, prepay and have medications delivered...
AI Falls Short on Differential Diagnosis, Despite High Accuracy Rates
A JAMA Network Open study from Mass General Brigham evaluated 21 large language models on structured patient scenarios. The models achieved over 90 % accuracy in identifying the final diagnosis when given complete clinical information, but they struggled to generate appropriate...
After Apellis Deal, Biogen Looks to Fill Early-Stage Pipeline
Biogen announced a $5.6 billion acquisition of Apellis Pharmaceuticals, adding a complement‑inhibition platform to its portfolio. While the deal closes this month, the company emphasized that its growth engine will now hinge on early‑stage development and research rather than late‑stage launches....
Brenntag Pharma Unveiled BYPHAR, the New Regulated Biopharma Manufacturing Brand
Brenntag Pharma introduced BYPHAR, a new regulated biopharma manufacturing brand that consolidates high‑quality raw materials, advanced facilities, and value‑added services into a single, compliance‑ready portfolio. The brand groups materials into three tiers—Explore, Enhance, and Excel—covering non‑GMP to LBLE critical grades,...
Circio Partners with TraffikGene Project to Advance Non-Viral circVec Delivery
Circio, an Oslo‑based circular RNA company, has partnered with the Universidad de Santiago de Compostela’s TraffikGene project to explore non‑viral delivery of its circVec circular RNA expression vectors. The collaboration merges Circio’s circVec platform with TraffikGene’s peptide amphiphile carrier system...
Top Cardiology News for April 2026
TCTMD’s Heart Sounds podcast paid tribute to cardiology legend Eugene Braunwald, underscoring his decades‑long influence on clinical practice and research. The episode also curated the team’s top cardiology studies from the past weeks, spanning AI‑driven ECG analysis, a novel SGLT2...
Healthy Workers Are Ditching Company Insurance to Save $1,000 a Month
Rising health‑care premiums are prompting healthy, young workers to abandon employer‑sponsored insurance in favor of cheaper alternatives. A Buffalo nurse and her family saved $970 per month by joining a medical‑cost‑sharing cooperative and enrolling their children in a state child‑health...
Assisted Death Need of People Whose Life Is Living Hell, Difficulties Are Stupendous Re: Assisted Dying Bill Supporters Vow to...
A physician’s open letter to the BMJ highlights the ethical and legal quagmire surrounding assisted dying for patients in vegetative states and terminal illness. The author raises four core questions: who can request, who decides, what criteria apply, and who...
PFA's Dominance and Other Key Electrophysiology Trends on Display at Heart Rhythm 2026
Pulse‑field ablation (PFA) is emerging as a durable, safer alternative for atrial fibrillation, delivering higher first‑pass isolation rates and fewer repeat procedures. Experts predict a dual‑energy future where PFA and radiofrequency ablation (RFA) are combined to treat thicker tissue and...
Biogen Ready to Catch Alzheimer’s Patients Transitioning Off Lilly’s Kisunla
Biogen is positioning its Leqembi therapy to capture Alzheimer’s patients who will finish Eli Lilly’s 18‑month Kisunla regimen and need a maintenance option. Leqembi, approved in January 2023, saw a 74% year‑over‑year sales jump to $168 million in Q1 2026, beating expectations. Biogen is...
The Best Possible Patient Outcome Goes Beyond Prior Authorization
Brian Smith, chief pharmacy officer at Shields Health Solutions, argues that prior authorization alone fails patients who cannot afford prescribed drugs. He emphasizes that true patient care must address financial barriers alongside clinical approval processes. Shields Health is promoting a...
The Trump Team Is Quietly Eliminating U.S. Support for Birth Control Abroad
The Trump administration has stopped spending the $575 million Congress appropriated for international family‑planning, effectively ending U.S. support for birth‑control programs abroad. The cuts have shuttered clinics, fired community health workers like Uganda’s Prossy Muyingo, and created a shortfall that threatens...
AstraZeneca’s £300m UK Return Shows the Price Britain Paid to Win Back Pharma Money
AstraZeneca is restarting a £300 million (≈$380 million) research investment in the UK after the UK‑US pharmaceutical agreement boosted expected returns. The plan funds the completion of the Rosalind Franklin building in Cambridge and a new digital drug‑development lab, reflecting higher NHS...
Healthcare AI News 4/29/26
Central Maine Healthcare announced the layoff of 38 IT workers as Maine pushes a statewide, Wisconsin‑based electronic health record (EHR) platform. The state is committing public funds to the vendor despite ongoing antitrust scrutiny, mirroring concerns raised by Memorial Sloan...
AI-Driven Layoffs In Healthcare: Navigating Legal Risks and Operational Challenges
Artificial intelligence is accelerating workforce reductions across sectors, and healthcare is feeling the impact. Large employers such as Amazon, UPS and Verizon have announced tens of thousands of AI‑related cuts, while a Utah physician‑owned network and CVS Health have trimmed...
Prior Auth Challenges Mount as Demand Proliferates
Prior authorization (PA) requests are surging, with industry data showing a 22% year‑over‑year increase in volume across U.S. health systems. Clinicians, like Shields Health Solutions’ chief pharmacy officer Brian Smith, acknowledge growing frustration as each PA adds an average 15‑minute...
Inside Servier’s New €200M Venture Fund
Servier has unveiled a new corporate venture fund, committing roughly $216 million to back early‑stage biotech focused on oncology and neurology. The fund, Servier Ventures, will target late pre‑clinical and Series A assets where it can add capital and industrial expertise, especially...
How Disintermediation Is Being Managed in Rx Models
Employers are moving away from traditional, single‑vendor pharmacy benefit managers, with transparent PBM adoption climbing to 31% in 2025 from 12% in 2024. This disintermediation creates multi‑vendor configurations that split claims, rebates, specialty management, and clinical navigation across separate partners....
Rad AI Appoints Chief Operating Officer and First Chief Clinical Officer, Strengthening Operational and Clinical Strategy
Rad AI announced the promotion of David Leonard to chief operating officer and the appointment of Dr. Elizabeth Bergey as its first chief clinical officer. Leonard, formerly head of operations, strategy and investor relations, will oversee global operations and drive...
Re: Overcommercialisation of Dental Practice in England and Decline in Oral Health
In a rapid response to a BMJ article on England’s over‑commercialised dental sector, Russian reviewer Sergei Jargin highlights similar market‑driven pressures and oral‑health inequities in Russia today. He contrasts the current situation with Soviet‑era practices, where children received crude extractions...
Rula State of Mental Health Report 2026: Financial Stress and AI Chatbot Trends in Behavioral Healthcare
Rula’s 2026 State of Mental Health Report, based on a survey of 2,037 U.S. adults, reveals a widening gap between mental‑health awareness and actual service use. Financial stress is the top barrier, with 25% citing cost and half cutting health...
Candel Therapeutics Announces Commercial Agreement with EVERSANA to Support U.S. Launch of Prostate Cancer Therapy
Candel Therapeutics announced a commercialization agreement with EVERSANA to support the potential U.S. launch of its gene‑therapy candidate aglatimagene besadenovec (CAN‑2409) for intermediate‑ to high‑risk localized prostate cancer. EVERSANA will deliver a full suite of services, including data analytics, medical...
Zócalo Health Finds Growth in Medicaid Managed Care Partnerships
Zócalo Health closed a $15 million Series A round, bringing total capital to $22.75 million, to scale its virtual primary‑care platform for underserved Latino patients. The company has moved beyond its California launch, now serving Medicaid members in California, Texas, Washington and expanding...
Financial Assistance Reform Is Reshaping Revenue Cycle Strategy
In 2026 a wave of state financial‑assistance reforms turns hospital affordability from guidance into enforceable law. Laws such as Maine’s LD 1937 require mandatory income‑based payment plans, pause collections during eligibility review, and impose multilingual disclosures. Similar statutes in Maryland, Oregon,...
Beyond Support Teams: The Strategic Role of Centers of Excellence in Healthcare
Healthcare systems are channeling new technology dollars into Centers of Excellence (COEs) to tackle workforce shortages, regulatory pressure, and EHR fatigue. A COE is positioned as a governance and execution model that aligns technology choices with clinical, financial, and operational...
Chiesi Signs $1.9B Deal to Acquire KalVista and Its Approved Drug
Italian pharmaceutical group Chiesi announced a $1.9 billion cash acquisition of U.S. biotech KalVista Pharmaceuticals, paying $27 per share. KalVista brings an FDA‑approved therapy for a rare disease into Chiesi’s portfolio, bolstering its specialty drug offerings. The deal is part of...
AstraZeneca Bullish on $80B Sales Goal After Beating Expectations, Phase 3 Data Wins
AstraZeneca reported first‑quarter sales of $15.3 billion, surpassing the $14.7 billion consensus estimate and delivering 8% constant‑currency growth. The surge was led by oncology products Enhertu and Imfinzi, while the rare‑disease unit contributed $2.4 billion, anchored by Ultomiris. New alliance revenue from the...
Chiesi Expands Rare Disease Portfolio, Acquires KalVista for $1.9 Billion
Chiesi Group announced a $1.9 billion cash acquisition of KalVista Pharmaceuticals, its largest deal to date. The purchase adds EKTERLY (sebetralstat), the first oral, on‑demand therapy for hereditary angioedema (HAE), to Chiesi’s rare‑disease pipeline. EKTERLY is already approved in major markets...
Why the GLP-1 Boom Has a Litigation Wave Right Behind It
GLP‑1 receptor agonists such as semaglutide and tirzepatide have surged from diabetes treatment to popular weight‑loss drugs, creating a multi‑billion‑dollar market. Their rapid adoption across physician offices, weight‑loss centers, compounding pharmacies, and online platforms has exposed gaps in patient screening,...
STAT+: Pharmalittle: We’re Reading About the FDA Speeding up Trials, a Supreme Court Hearing on ‘Skinny Labels,’ and More
The FDA announced a pilot program that will review real‑time data from AstraZeneca and Amgen cancer trials using a platform built by Paradigm Health, aiming to speed regulatory feedback. The agency also opened a public comment period on a separate...
On the Move: Penn State Health Names Royer PR Chief
Penn State Health announced the appointment of Dara Royer as senior vice president and chief marketing and communications officer, effective June 29. Royer arrives from Syracuse University after senior roles at Mercy Corps and St. Jude Children’s Research Hospital. At the...
Expansion Planned for Assisted Living Facility at 2820 Sycamore Ave. In Glendale
Episcopal Communities & Services plans to expand its Twelve Oaks assisted‑living campus at 2820 Sycamore Avenue in Glendale. The developer will demolish 12 existing structures that house 60 residents and replace them with a three‑story, 92,240‑square‑foot building offering 104 senior beds....
Pfizer Settles with Generic Drugmakers to Protect Blockbuster Drug Until 2031
Pfizer reached settlements with three generic manufacturers—Dexcel Pharma, Hikma Pharmaceuticals and Cipla—to postpone the launch of off‑patent copies of its heart‑disease drug Vyndamax until mid‑2031. The agreement stabilizes U.S. sales, which hit $3.8 billion in 2025, and averts the steep revenue...
Talkiatry and New York Cancer & Blood Specialists Partner to Expand Mental Health Access for Oncology Patients
New York Cancer & Blood Specialists (NYCBS) has partnered with telepsychiatry provider Talkiatry to embed psychiatric care into its oncology network. The collaboration will roll out across more than 30 NYCBS locations, giving patients access to over 300 board‑certified psychiatrists...